 | Up a level |
Andreas, Martin; Burri, Haran; Praz, Fabien; Soliman, Osama; Badano, Luigi; Barreiro, Manuel; Cavalcante, João L; de Potter, Tom; Doenst, Torsten; Friedrichs, Kai; Hausleiter, Jörg; Karam, Nicole; Kodali, Susheel; Latib, Azeem; Marijon, Eloi; Mittal, Suneet; Nickenig, Georg; Rinaldi, Aldo; Rudzinski, Piotr; Russo, Marco; ... (2024). Tricuspid valve disease and cardiac implantable electronic devices. European Heart Journal, 45(5), pp. 346-365. Oxford University Press 10.1093/eurheartj/ehad783
Abdelshafy, Mahmoud; Caliskan, Kadir; Simpkin, Andrew J; Elkoumy, Ahmed; Kimman, Jesse R; Elsherbini, Hagar; Elzomor, Hesham; de By, Theo M M H; Gollmann-Tepeköylü, Can; Berchtold-Herz, Michael; Loforte, Antonio; Reineke, David; Schoenrath, Felix; Paluszkiewicz, Lech; Gummert, Jan; Mohacsi, Paul; Meyns, Bart; Soliman, Osama (2023). Efficacy of levosimendan infusion in patients undergoing a left ventricular assist device implant in a propensity score matched analysis of the EUROMACS registry-the Euro LEVO-LVAD study. European journal of cardio-thoracic surgery, 63(5) Oxford University Press 10.1093/ejcts/ezad095
Ono, Masafumi; Kawashima, Hideyuki; Hara, Hironori; Gamal, Amr; Wang, Rutao; Gao, Chao; O'Leary, Neil; Soliman, Osama; Piek, Jan J; van Geuns, Robert-Jan; Jüni, Peter; Hamm, Christian W; Valgimigli, Marco; Vranckx, Pascal; Windecker, Stephan; Steg, Philippe Gabriel; Fox, Keith Aa; Onuma, Yoshinobu; Serruys, Patrick W (2021). External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial. Catheterization and cardiovascular interventions, 98(4), E513-E522. Wiley-Blackwell 10.1002/ccd.29772
Tomaniak, Mariusz; Chichareon, Ply; Takahashi, Kuniaki; Kogame, Norihiro; Modolo, Rodrigo; Chang, Chun Chin; Spitzer, Ernest; Neumann, Franz-Josef; Plante, Sylvain; Hernández Antolin, Rosana; Jambrik, Zoltan; Gelev, Valeri; Brunel, Philippe; Konteva, Mariana; Beygui, Farzin; Morelle, Jean-Francois; Filipiak, Krzysztof J; van Geuns, Robert-Jan; Soliman, Osama; Tijssen, Jan; ... (2020). Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial. European heart journal. Cardiovascular pharmacotherapy, 6(4), pp. 222-230. Oxford University Press 10.1093/ehjcvp/pvz052
Chang, Chun Chin; Spitzer, Ernest; Chichareon, Ply; Takahashi, Kuniaki; Modolo, Rodrigo; Kogame, Norihiro; Tomaniak, Mariusz; Komiyama, Hidenori; Yap, Sing-Chien; Hoole, Stephen P; Gori, Tommaso; Zaman, Azfar; Frey, Bernhard; Ferreira, Rui Cruz; Bertrand, Olivier F; Koh, Tian Hai; Sousa, Amanda; Moschovitis, Aris; van Geuns, Robert-Jan; Steg, Philippe Gabriel; ... (2019). Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial). The American journal of cardiology, 124(12), pp. 1833-1840. Elsevier 10.1016/j.amjcard.2019.08.049
Serruys, Patrick W; Takahashi, Kuniaki; Chichareon, Ply; Kogame, Norihiro; Tomaniak, Mariusz; Modolo, Rodrigo; Chang, Chun Chin; Komiyama, Hidenori; Soliman, Osama; Wykrzykowska, Joanna J; de Winter, Robbert J; Ferrario, Maurizio; Dominici, Marcello; Buszman, Paweł; Bolognese, Leonardo; Tumscitz, Carlo; Benit, Edouard; Stoll, Hans-Peter; Hamm, Christian; Steg, Philippe Gabriel; ... (2019). Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial. European heart journal, 40(31), pp. 2595-2604. Oxford University Press 10.1093/eurheartj/ehz453
